Insulin use in hospitalized patients with diabetes: Navigate with care

Diabetes Spectrum

Volumn 26, Issue 2, 2013, Pages 124-130

  Low Wang, Cecilia C ^a,b   Draznin, Boris ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; METHYLPREDNISOLONE; ORAL ANTIDIABETIC AGENT; PREDNISONE; STEROID;

BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; BODY MASS; DIABETES MELLITUS; DIABETIC PATIENT; DIALYSIS; ENTERIC FEEDING; HEMODIALYSIS; HOME; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; MEAL; NURSING HOME; NUTRITIONAL STATUS; OUTPATIENT CARE; PERITONEAL DIALYSIS; POINT OF CARE TESTING; REHABILITATION CENTER; REVIEW; TOTAL PARENTERAL NUTRITION;

EID: 84878157197     PISSN: 10409165     EISSN: 19447353     Source Type: Journal    
DOI: 10.2337/diaspect.26.2.124     Document Type: Review

References (32)

1. Centers for Disease Control and Prevention: National hospital discharge survey, 2010. Available from http://www.cdc.gov/nchs/data/nhds/1general/ 2010gen1-agesexalos.pdf. Accessed 20 February 2013
2. Lindner JL, Omalu BI, Buhari AM, Shakir A, Rozin L, Wecht CH: Nursing home deaths which fall under the jurisdiction of the coroner: an 11-year retrospective study. Am J Forensic Med Pathol 28:292-298, 2007 (Pubitemid 350190869)
3. Dartmouth Institute for Health Policy and Clinincal Practice: The DartMouth atlas of health care. Available from www.dartmouthatlas.org/data/ table.aspx?ind=15. Accessed 20 February 2013
4. Institute for Safe Medication Practices: ISMP high-alert medications. Available from http://www.ismp.org/Tools/highAlertMedication-Lists.asp. Accessed 20 February 2013
5. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL: National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858-1866, 2006 (Pubitemid 44596195)
6. U.S. Pharmacopeia: Press release: USP releases fourth annual report on medication errors in U.S. hospitals. Available from http://us.vocuspr.com/ Newsroom/ViewAttachment.aspx?SiteName=USPharm&Entity=PRAsset& AttachmentType=F&EntityID=73209&AttachmentID=6170a11a-4cd0-4ffc-a625- 94b03b1e1d33. Accessed 20 February 2013
7. Hsia E, Draznin B: Intensive control of diabetes in the hospital: why, how, and what is in the future? J Diabetes Sci Technol 5:1596-1601, 2011
8. Moss SE, Klein R, Klein BE: Risk factors for hospitalization in people with diabetes. Arch Intern Med 159:2053-2057, 1999 (Pubitemid 29453593)
9. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, Seley JJ, Van den Berghe G: Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 97:16-38, 2012
10. Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B: Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab 97:3132-3137, 2012
11. Avanzini F, Marelli G, Donzelli W, Busi G, Carbone S, Bellato L, Colombo EL, Foschi R, Riva E, Roncaglioni MC, De MM: Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care 34:1445-1450, 2011
12. Ramos P, Childers D, Maynard G, Box K, Namba J, Stadalman K, Renvall M: Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach. J Hosp Med 5:446-451, 2010
13. Weant KA, Ladha A: Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients. Ann Pharmacother 43:629-634, 2009
14. Furnary AP, Braithwaite SS: Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 98:557-564, 2006 (Pubitemid 44162888)
15. Olefsky JM, Kimmerling G: Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 271:202-210, 1976
16. Kalhan SC, Adam PA: Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. J Clin Endocrinol Metab 41:600-610, 1975
17. Dujovne CA, Azarnoff DL: Clinical complications of corticosteroid therapy: a selected review. Med Clin North Am 57:1331-1342, 1973
18. Seggelke SA, Gibbs J, Draznin B: Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med 6:175-176, 2011
19. Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira R, Hsia E, Draznin B: Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. J Diabetes Sci Technol 6:1038-1044, 2012
20. Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, Frankel AH, Tam FW, Dornhorst A, Frost G, Turner JJ: Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 32:1137-1142, 2009
21. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, Caudwell V, Ragot S, Bridoux F, Charpentier G, Marechaud R, Hadjadj S: Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 24:2866-2871, 2009
22. Sobngwi E, Enoru S, Ashuntantang G, Azabji-Kenfack M, Dehayem M, Onana A, Biwole D, Kaze F, Gautier JF, Mbanya JC: Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis. Diabetes Care 33:1409-1412, 2010
23. Selby NM, Fialova J, Burton JO, McIntyre CW: The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant 22:870-879, 2007 (Pubitemid 46351699)
24. Pennell P, Rojas C, Asif A, Rossini E: Managing metabolic complications of peritoneal dialysis. Clin Nephrol 62:35-43, 2004 (Pubitemid 38979107)
25. Ziegler TR: Parenteral nutrition in the critically ill patient. N Engl J Med 361:1088-1097, 2009
26. Cheung NW, Napier B, Zaccaria C, Fletcher JP: Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 28:2367-2371, 2005 (Pubitemid 41384278)
27. Olveira G, Tapia MJ, Ocon J, Cabrejas-Gomez C, Ballesteros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-Garcia MD, Garcia-Manzanares A, Botella-Romero F, Quilez-Toboso RP, Cabrerizo L, Matia P, Chicharro L, Burgos R, Pujante P, Ferrer M, Zugasti A, Prieto J, Dieguez M, Carrera MJ, Vila-Bundo A, Urgeles JR, Aragon-Valera C, Rovira A, Breton I, Garcia-Peris P, Munoz-Garach A, Marquez E, Del OD, Pereira JL, Tous MC: Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients increases the risk of in-hospital mortality (multicenter study). Diabetes Care (Electronically published ahead of print on 6 December 2012; doi: 10.2337/dc12-1379)
28. Umpierrez GE: Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care 32:751-753, 2009
29. Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B: Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract 26:714-717, 2011
30. Baldwin D, Kinnare K, Draznin B, Seggelke SA, Rinsley JS, Gandhi S, Bhalani V, Braithwaite SS, Srinivasan C, Heintz K, Dungan KM, Bernard J, Edgren A, Diaz J, Aronson M, Barnosky A, Emanuele M: Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN) [Abstract]. Diabetes 61:A275, 2012
31. Bergenstal RM, Fahrbach JL, Iorga SR, Fan Y, Foster SA: Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization. Endocr Pract 18:371-375, 2012
32. Griffith ML, Boord JB, Eden SK, Matheny ME: Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J Clin Endocrinol Metab 97:2019-2026, 2012